Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2024-03-19 Investor Presentation
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a letter addressed to stock exchanges providing an update on the schedule of an investor meeting (Bharat Connect Conference) on 26th March 2024. It references compliance with SEBI Listing Regulations and clarifies that no unpublished price sensitive information will be discussed. The document is short (1851 characters) and serves as an announcement of an upcoming investor event rather than containing financial data, management discussion, or detailed presentation content. It does not contain financial statements or detailed analysis, so it is not an Interim Report, Annual Report, or Earnings Release. It is not a transcript or voting result. The content fits best as an Investor Presentation update or meeting schedule notice. Given the nature of the document as an update on an investor meeting schedule, the most appropriate classification is Investor Presentation (IP).
2024-03-19 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India responding to a query about the signing of financial results for the quarter ended December 31, 2023. It includes a certified copy of a board resolution approving the unaudited financial results for the quarter and nine months ended December 31, 2023. The document does not contain the financial results themselves but rather a compliance explanation and authorization related to the submission of those results. The length is 3113 characters, which is relatively short and the content is primarily a regulatory response and certification of board approval. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a compliance communication and not the financial report itself or a full management discussion or earnings release.
2024-03-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 14th March 2024 addressed to stock exchanges about a scheduled analyst/investor meeting held on 12th March 2024. It explicitly states that no unpublished price sensitive information was shared and provides details of the meeting type and participants. The document is brief (1516 characters) and serves as an update or announcement rather than containing any financial data, analysis, or detailed presentation. It does not contain financial statements or substantive financial data, nor is it a transcript or report. It is an announcement related to investor relations activities, specifically an update on a scheduled analyst/investor meet. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-03-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the company's management participation in an upcoming investor conference organized by Arihant Capital. It references compliance with SEBI Listing Regulations and explicitly states that no unpublished price sensitive information will be discussed. The document is short (1978 characters) and serves as an announcement of a management event rather than containing any financial data, report, or detailed presentation. It does not contain financial statements, audit information, voting results, or any other report content. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing the stock exchanges about a scheduled analyst/investor meeting. It explicitly states that no unpublished price sensitive information will be discussed and is primarily a notification of an upcoming event rather than a report or detailed presentation. The document length is short (1553 characters) and does not contain financial data or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance notifications that do not fit other categories.
2024-03-06 English
Scheme of Arrangement
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the withdrawal of a previously approved Scheme of Arrangement for amalgamation between two companies. It references regulatory compliance under SEBI Listing Regulations and the Companies Act, 2013. The content is an announcement of a corporate action being withdrawn, not a detailed report, financial statement, or presentation. The document length is short (2750 characters), and it serves as an official intimation or regulatory announcement rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.